<DOC>
	<DOCNO>NCT00088179</DOCNO>
	<brief_summary>During heart bypass procedure , substance call `` complement '' activate body . This `` complement activation '' cause inflammatory response lead side affect chest pain , heart attack , stroke , heart failure , death . The purpose study find study drug ( pexelizumab ) , block `` complement activation , '' reduce side effect give safely patient require bypass procedure use heart-lung machine .</brief_summary>
	<brief_title>Pexelizumab Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass ( PRIMO-CABG II )</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>least 18 year age ; 2 follow risk factor : • diabetes mellitus ; • repeat CABG ; • need urgent intervention , define accord ACC/AHA guideline patient require stay hospital due medical factor , may schedule operate within normal schedule routine , exclude patient MI within 48 hour CABG ; • female ; • history neurologic event ( cerebrovascular accident , transient ischemic attack carotid endarterectomy ) ; • history congestive heart failure ( NYHA CHF Class III IV ) ; • history 2 MIs , MI occur great 48 hour less 4 week prior CABG ; provide Informed Consent . require salvage intervention define ACC/AHA guideline 10 ongoing cardiopulmonary resuscitation way operate room ; current cardiogenic shock , acute leave ventricular rupture , acute septal rupture acute papillary muscle rupture ; active bacterial infection clinically significant , opinion Investigator ( e.g . evaluate evidence base WBC , temperature , culture etc . appropriate patient ) ; know suspect hereditary complement deficiency ; participate investigational drug study expose investigational agent device within 30 day randomization ; receiving , plan receive , investigational drug device , participate research study within 30 day randomization ; pregnant breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>CABG</keyword>
	<keyword>CPB</keyword>
</DOC>